M&T BANK CORP - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 177 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$208,506
-36.3%
4,006
-22.6%
0.00%0.0%
Q2 2023$327,411
+7.3%
5,174
-8.3%
0.00%0.0%
Q1 2023$305,125
-54.8%
5,643
-64.2%
0.00%0.0%
Q4 2022$674,672
+146.2%
15,767
+167.8%
0.00%0.0%
Q3 2022$274,000
+29.9%
5,888
+59.5%
0.00%0.0%
Q2 2022$211,000
-34.5%
3,692
-29.7%
0.00%0.0%
Q1 2022$322,000
-9.6%
5,252
-22.8%
0.00%0.0%
Q4 2021$356,000
+41.8%
6,804
+1.2%
0.00%0.0%
Q3 2021$251,000
-15.5%
6,722
-7.6%
0.00%0.0%
Q2 2021$297,000
+24.3%
7,271
+3.6%
0.00%0.0%
Q1 2021$239,000
-31.3%
7,015
-36.0%
0.00%
-50.0%
Q4 2020$348,000
-32.8%
10,953
-45.7%
0.00%
-33.3%
Q3 2020$518,000
+18.0%
20,176
+18.0%
0.00%
+50.0%
Q2 2020$439,000
+143.9%
17,105
+45.7%
0.00%
+100.0%
Q1 2020$180,000
-45.5%
11,736
+42.3%
0.00%
-50.0%
Q3 2015$330,0008,2500.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 700,000$42,833,0008.57%
SILVERARC CAPITAL MANAGEMENT, LLC 308,819$18,897,0007.82%
Vahanian & Associates Financial Planning Inc. 45,533$2,786,0006.44%
DCF Advisers, LLC 238,500$14,594,0006.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 50,956$20,930,0004.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,531,923$93,738,0002.86%
Nicholas Investment Partners, LP 562,373$34,412,0002.45%
Bellevue Group AG 3,429,619$209,859,0002.44%
WASATCH ADVISORS LP 7,477,868$457,571,0002.25%
Quantum Private Wealth, LLC 73,772$4,514,0001.95%
View complete list of INTRA CELLULAR THERAPIES INC shareholders